ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Different properties between patients with combined pulmonary fibrosis and emphysema and patients with idiopathic pulmonary fibrosis.

Fatma Demirci Üçsular ,Gülistan Karadeniz,Gülru Polat,Hülya Şahin,Hatice Solmaz,Enver Yalnız,Filiz Güldaval,Melih Büyükşirin.



Abstract
Download PDF Cited by 0 ArticlesPost

Aim: Combined pulmonary fibrosis and emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) have been discussed intensively in recent years as two different entities. We aimed to compare the clinical, functional and respiratory parameters, clinical course and mortality rates of patients with CPFE with IPF.
Materials and Methods: 36 patients with a diagnosis of CPFE and 40 IPF who applied between September 2013 and February 2019 were retrospectively included in the study. Demographic data, comorbidities, pulmonary function parameters, life surveys, systolic pulmonary artery pressures(sPAP) detected.
Results: In the CPFE patient group, While the ratio of male patients (p=0.02), smoking (p

Key words: Combined pulmonary fibrosis and emphysema; idiopathic pulmonary fibrosis; mortality; pulmonary function tests; pulmonary hypertension.







Bibliomed Article Statistics

24
35
36
16
22
22
17
19
29
29
27
1
R
E
A
D
S

11

17

9

11

9

11

16

11

17

15

8


D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.